Regulation & Compliance

Southwestern Asset Management launches a new fund for leasing dairy cattle, offering a unique play on real assets, tax benefits, and agricultural finance.

Global investment firm KKR agrees to privatize electronics leader Taiyo Holdings, aiming to fuel long-term innovation beyond public market pressures.

A new survey reveals bank leaders are worried about AI-driven fraud and competition but lack understanding of advanced AI, creating significant new risks.

With a fresh $21.5M in funding, Variance is deploying autonomous AI agents to transform how banks and enterprises combat sophisticated financial crime.

A new federal grant positions Connecticut's HIE to solve a major privacy hurdle, testing tech that could transform care for SUD patients nationwide.

A key U.S. patent extends protection for a promising CRPS-1 drug, paving the way for a potential first-in-class treatment for the debilitating condition.

Construction starts on Canada's next-gen polar icebreaker, a project to secure Arctic sovereignty, create jobs, and test a new international shipbuilding model.

A new intelligence firm is ditching child surveillance to fight online harm by exposing platform design flaws and arming lawsuits against Big Tech.

A new partnership provides early access to an investigational drug for FAP, offering a potential non-surgical therapeutic option for the first time.

Tech veteran Mariana Catz takes the helm at reSolved, as founder Malcolm Klotz shifts to CTO to spearhead AI innovation and global market expansion.

Publicly traded C1 Fund has acquired a position in Uphold, a move validating the multi-asset platform and highlighting Wall Street's growing crypto appetite.

The card-issuing platform's new AI risk score analyzes transactions in milliseconds, aiming to fight advanced fraud while reducing costly false declines.

Final trial data shows pralsetinib offers years of survival for RET+ lung cancer, but realizing its full potential hinges on overcoming diagnostic hurdles.

As a wall of corporate debt looms over Europe, the investment firm hires a top specialist to lead its expansion and capitalize on market dislocations.

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

A new bipartisan bill introduced at the TMCF Fly-In aims to overhaul federal research funding access for HBCUs, addressing a stark inequity in STEM.

In a stunning rebuke, a judge warns of 'criminal consequences' as a charity's fight for survival puts government secrecy and accountability on trial.

A new AI trading bot, MoneyFlare, claims to make crypto investing effortless. But can a 'zero learning curve' platform truly tame a notoriously volatile market?

With new CTO Zack Moy, AI-native TPA Elysian aims to solve insurance's most complex data problems, blending machine intelligence with human expertise.

As Catholic Church bankruptcy settlements advance, survivors face a complex reality: long-awaited payouts aided by high-cost litigation funding firms.